CSIR Technology Portal
CSIR Technology Portal

 Technology Profile

Title:

Continuous and Green (Solvent-free) Process for the Manufacturing of Metformin Hydrochloride (an anti-diabetic drug)

Value Proposition:
  • Continuous process
  • Shorter reaction time
  • Single-step process
  • Colourless product
  • Green process: No use of organic solvent
  • Cost-effective process: Solvent-free, no product purification step
  • Smaller footprint
  • Complete conversion of reactants
  • Product quality complies with FDA regulatory criteria and standards.
Summary Application:
  • Anti-diabetic drug for Type II Diabetes
  • For women with Polycystic Ovary Syndrome
Advantages:
  • Solvent-free, additive-free, and greener production technology
  • Single-step reaction with continuous mode by use of a screw reactor
  • Low reaction time (5 to 10 min) as compared to the existing process
  • High-purity product with less downstreaming process (>95%)
  • Easier scale-up to industrial production.
Commercialization Status: Licensed awaiting commercialisation
Tech. Readiness Level:
CSIR-National Chemical Laboratory
CSIR-National Chemical Laboratory[CSIR-NCL]
:  director[at]ncl[dot]res[dot]in
:91-20- 25902600, 25902028
:http://www.ncl-india.org/
Industrial Applications: Drug delivery [Drugs and Pharmaceuticals]
Patent(s): EP4025560 IN462869
Patent Application(s): US20220274917, WO2021044445